期刊
EMBO JOURNAL
卷 32, 期 6, 页码 816-828出版社
WILEY
DOI: 10.1038/emboj.2013.28
关键词
dendritic cells; I kappa B Kinase alpha; interferon regulatory factor 3; T-cell priming
资金
- L'Agence Nationale de la Recherche (ANR) [ANR-09-MIEN-029-01, ANR-10-BLAN-1302-01]
- INSERM
- CNRS
- Universite Aix-Marseille
- FIRC
- FRM
- NIH [AI043477, AI57153]
- Agence Nationale de la Recherche (ANR) [ANR-10-BLAN-1302] Funding Source: Agence Nationale de la Recherche (ANR)
- Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom
Dendritic cells (DC) are required for priming antigen-specific T cells and acquired immunity to many important human pathogens, including Mycobacteriuim tuberculosis (TB) and influenza. However, inappropriate priming of auto-reactive T cells is linked with autoimmune disease. Understanding the molecular mechanisms that regulate the priming and activation of naive T cells is critical for development of new improved vaccines and understanding the pathogenesis of autoimmune diseases. The serine/threonine kinase IKK alpha (CHUK) has previously been shown to have anti-inflammatory activity and inhibit innate immunity. Here, we show that IKK alpha is required in DC for priming antigen-specific Tcells and acquired immunity to the human pathogen Listeria monocytogenes. We describe a new role for IKK alpha in regulation of IRF3 activity and the functional maturation of DC. This presents a unique role for IKK alpha in dampening inflammation while simultaneously promoting adaptive immunity that could have important implications for the development of new vaccine adjuvants and treatment of autoimmune diseases. The EMBO Journal (2013) 32, 816-828. doi:10.1038/emboj.2013.28; Published online 19 February 2013
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据